186 related articles for article (PubMed ID: 30968304)
1. Evaluation of Hydrogenated Soybean Phosphatidylcholine Matrices Prepared by Hot Melt Extrusion for Oral Controlled Delivery of Water-Soluble Drugs.
Kolbina M; Schulte A; van Hoogevest P; Körber M; Bodmeier R
AAPS PharmSciTech; 2019 Apr; 20(4):159. PubMed ID: 30968304
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of extended release Kollidon SR mini-matrices prepared by hot-melt extrusion.
Ozgüney I; Shuwisitkul D; Bodmeier R
Eur J Pharm Biopharm; 2009 Sep; 73(1):140-5. PubMed ID: 19406237
[TBL] [Abstract][Full Text] [Related]
3. Saturated phosphatidylcholine as matrix former for oral extended release dosage forms.
Kolbina M; Bodmeier R; Körber M
Eur J Pharm Sci; 2017 Oct; 108():86-92. PubMed ID: 28716757
[TBL] [Abstract][Full Text] [Related]
4. Continuous production of controlled release dosage forms based on hot-melt extruded gum arabic: Formulation development, in vitro characterization and evaluation of potential application fields.
Kipping T; Rein H
Int J Pharm; 2016 Jan; 497(1-2):36-53. PubMed ID: 26617317
[TBL] [Abstract][Full Text] [Related]
5. Hydrophilic thermoplastic polyurethanes for the manufacturing of highly dosed oral sustained release matrices via hot melt extrusion and injection molding.
Verstraete G; Van Renterghem J; Van Bockstal PJ; Kasmi S; De Geest BG; De Beer T; Remon JP; Vervaet C
Int J Pharm; 2016 Jun; 506(1-2):214-21. PubMed ID: 27113866
[TBL] [Abstract][Full Text] [Related]
6. Properties of hot-melt extruded theophylline tablets containing poly(vinyl acetate).
Zhang F; McGinity JW
Drug Dev Ind Pharm; 2000 Sep; 26(9):931-42. PubMed ID: 10914317
[TBL] [Abstract][Full Text] [Related]
7. Hot melt extruded zein for controlled delivery of diclofenac sodium: Effect of drug loading and medium composition.
Bisharat L; Alkhatib HS; Abdelhafez A; Barqawi A; Aljaberi A; Qi S; Berardi A
Int J Pharm; 2020 Jul; 585():119503. PubMed ID: 32502688
[TBL] [Abstract][Full Text] [Related]
8. Controlled release of a poorly water-soluble drug from hot-melt extrudates containing acrylic polymers.
Zhu Y; Shah NH; Malick AW; Infeld MH; McGinity JW
Drug Dev Ind Pharm; 2006 Jun; 32(5):569-83. PubMed ID: 16720412
[TBL] [Abstract][Full Text] [Related]
9. Melt extruded helical waxy matrices as a new sustained drug delivery system.
Hasa D; Perissutti B; Grassi M; Zacchigna M; Pagotto M; Lenaz D; Kleinebudde P; Voinovich D
Eur J Pharm Biopharm; 2011 Nov; 79(3):592-600. PubMed ID: 21827851
[TBL] [Abstract][Full Text] [Related]
10. Ethylene vinyl acetate as matrix for oral sustained release dosage forms produced via hot-melt extrusion.
Almeida A; Possemiers S; Boone MN; De Beer T; Quinten T; Van Hoorebeke L; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2011 Feb; 77(2):297-305. PubMed ID: 21168487
[TBL] [Abstract][Full Text] [Related]
11. Thermoplastic polyurethanes for the manufacturing of highly dosed oral sustained release matrices via hot melt extrusion and injection molding.
Claeys B; Vervaeck A; Hillewaere XK; Possemiers S; Hansen L; De Beer T; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2015 Feb; 90():44-52. PubMed ID: 25448075
[TBL] [Abstract][Full Text] [Related]
12. Diclofenac sodium sustained release hot melt extruded lipid matrices.
Vithani K; Cuppok Y; Mostafa S; Slipper IJ; Snowden MJ; Douroumis D
Pharm Dev Technol; 2014 Aug; 19(5):531-8. PubMed ID: 23763447
[TBL] [Abstract][Full Text] [Related]
13. A comparative study between melt granulation/compression and hot melt extrusion/injection molding for the manufacturing of oral sustained release thermoplastic polyurethane matrices.
Verstraete G; Mertens P; Grymonpré W; Van Bockstal PJ; De Beer T; Boone MN; Van Hoorebeke L; Remon JP; Vervaet C
Int J Pharm; 2016 Nov; 513(1-2):602-611. PubMed ID: 27686052
[TBL] [Abstract][Full Text] [Related]
14. Novel Hot Melt Extruded Matrices of Hydroxypropyl Cellulose and Amorphous Felodipine-Plasticized Hydroxypropyl Methylcellulose as Controlled Release Systems.
Yi S; Wang J; Lu Y; Ma R; Gao Q; Liu S; Xiong S
AAPS PharmSciTech; 2019 Jun; 20(6):219. PubMed ID: 31201583
[TBL] [Abstract][Full Text] [Related]
15. The Development of Direct Extrusion-Injection Moulded Zein Matrices as Novel Oral Controlled Drug Delivery Systems.
Bouman J; Belton P; Venema P; van der Linden E; de Vries R; Qi S
Pharm Res; 2015 Aug; 32(8):2775-86. PubMed ID: 25777612
[TBL] [Abstract][Full Text] [Related]
16. Melt Extrusion for a High Melting Point Compound with Improved Solubility and Sustained Release.
Lu J; Obara S; Liu F; Fu W; Zhang W; Kikuchi S
AAPS PharmSciTech; 2018 Jan; 19(1):358-370. PubMed ID: 28741140
[TBL] [Abstract][Full Text] [Related]
17. Influence of sulfobutyl ether beta-cyclodextrin (Captisol) on the dissolution properties of a poorly soluble drug from extrudates prepared by hot-melt extrusion.
Fukuda M; Miller DA; Peppas NA; McGinity JW
Int J Pharm; 2008 Feb; 350(1-2):188-96. PubMed ID: 17920217
[TBL] [Abstract][Full Text] [Related]
18. Properties of lipophilic matrix tablets containing phenylpropanolamine hydrochloride prepared by hot-melt extrusion.
Liu J; Zhang F; McGinity JW
Eur J Pharm Biopharm; 2001 Sep; 52(2):181-90. PubMed ID: 11522484
[TBL] [Abstract][Full Text] [Related]
19. Properties of melt extruded enteric matrix pellets.
Schilling SU; Shah NH; Waseem Malick A; McGinity JW
Eur J Pharm Biopharm; 2010 Feb; 74(2):352-61. PubMed ID: 19782133
[TBL] [Abstract][Full Text] [Related]
20. Development of sustained and dual drug release co-extrusion formulations for individual dosing.
Laukamp EJ; Vynckier AK; Voorspoels J; Thommes M; Breitkreutz J
Eur J Pharm Biopharm; 2015 Jan; 89():357-64. PubMed ID: 25555454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
